Churchill Capital XI - Unit

Churchill Capital XI - Unit released FY2026 Q1 earnings on May 13 (EST), actual revenue USD 0, actual EPS USD 0.0569

Churchill Capital XI - Unit released FY2025 Q4 earnings on March 26 (EST), actual revenue USD 0, actual EPS USD 0.0224

Churchill Capital XI - Unit released FY2025 Annual Earnings on March 26 (EST) with actual revenue of USD 0 and EPS of USD 0

Churchill Capital XI - Unit released FY2025 Q2 earnings on August 6, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0029

Netcapital

Agape ATP

Tradr 2X Long QBTS Daily ETF

Akanda

Defiance Daily Target 2X Long RGTI ETF

PicoCELA

Tradr 2X Long RGTI Daily ETF

Co-Diagnostics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

CCXIU

Earnings Watch

Churchill Capital XI - Unit | 10-Q: FY2026 Q1 Revenue: USD 0

CCCXU

Churchill Capital Corp XII Completes Upsized $414 Million Initial Public Offering | CXII Stock News

StockTitan

Churchill Capital Corp X - Unit

Churchill Capital Corp XII Completes Upsized $414 Million Initial Public Offering | CXII Stock News

CCCX

CCCXW

Churchill Capital XII, a SPAC founded by Michael Klein, has raised $360 million through an IPO by offering 36 million units at $10 each. Each unit includes one share of common stock and a warrant. The SPAC aims to target businesses with recurring revenue and strong management teams. Klein's previous SPACs include Churchill Capital XI and X, with various outcomes. The company will trade on Nasdaq under the symbol CXIIU, with Citi as the sole bookrunner.

RenaissanceCapital

Churchill Capital X

CHURCHILL CAPITAL CORP X C/WTS 14/05/2030(TO PUR COM)

SPAC & New Issue ETF

Citigroup

Infleqtion

Churchill Capital Corp IX

Lucid

Claritev

Infleqtion, Inc.

CITIGROUP INC 6.250 NON CUM SER II PFD WI

INFLEQTION INC C/WTS 17/02/2031 (TO PUR COM)

CLARITEV CORPORATION C/WTS 08/10/2025(TO PUR COM)

Michael Klein's SPAC Churchill Capital XII prices upsized $360 million IPO

Churchill Capital Corp XII Announces the Pricing of Upsized $360 Million Initial Public Offering | CXII Stock News

Churchill Capital Corp XII Announces the Pricing of Upsized $360 Million Initial Public Offering  | CXII Stock News

SPCK

Churchill Capital XII, a SPAC founded by Michael Klein, has filed for a $300 million IPO with the SEC. The company aims to offer 30 million units at $10 each, with each unit comprising one share of common stock and one-tenth of a warrant. The SPAC will target businesses with recurring revenue and stable cash flow. Klein's previous SPACs include successful mergers and some liquidations. The company plans to list on Nasdaq under the symbol CXIIU, with Citi as the sole bookrunner.

SPAC and New Issue ETF

Michael Klein's SPAC Churchill Capital XII files for a $300 million IPO

Churchill Capital XI - Unit | 10-K: FY2025 Revenue: USD 0

INFQ

Churchill Capital Corp XI announced that starting February 9, 2026, holders of units from its initial public offering can separately trade Class A ordinary shares and warrants. The shares will trade under the symbols "CCXI" and the warrants under "CCXIW" on the Nasdaq Global Market. Units that are not separated will continue to trade under "CCXIU." This announcement does not constitute an offer to sell or solicit securities in jurisdictions where it would be unlawful.

fidelity

Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026

Churchill Capital XI - Unit(CCXIU.US)

Churchill Capital XI - Unit | 10-Q: FY2026 Q1 Revenue: USD 0

Churchill Capital Corp XII Completes Upsized $414 Million Initial Public Offering | CXII Stock News

Michael Klein's SPAC Churchill Capital XII prices upsized $360 million IPO

Churchill Capital Corp XII Announces the Pricing of Upsized $360 Million Initial Public Offering | CXII Stock News

Michael Klein's SPAC Churchill Capital XII files for a $300 million IPO

Churchill Capital XI - Unit | 10-K: FY2025 Revenue: USD 0

Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026